PRPO · Precipio, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“Notwithstanding the aforementioned circumstances, there remains substantial doubt about the Company's ability to continue as a going concern over the next twelve months from the date of issuance of this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 14, 2026
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Sep 22, 2023; bars on opposite sides are not compared.
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $0.4M | Q2-26 | — |
|
|
|||
| cases | 4,652 | the three months ended June 30, 2026 filing | +26.0% |
|
|
|||
| Cash flow generated from operations | $0.7M | Q2-2026 | — |
| Adjusted operating cash flow non-GAAP | 727K | full year 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PRPO
this stock
Precipio, Inc.
|
$54.51M | +32.5% | +29.8% | — | 2.1% |
|
TMO
Thermo Fisher Scientific Inc.
|
$232.67B | +8.6% | +14.5% | 33.9 | 1.3% |
|
DHR
Danaher Corp /De/
|
$153.85B | -4.4% | +8.5% | 38.8 | 1.7% |
|
NTRA
Natera, Inc.
|
$47.86B | +44.9% | -2.8% | — | 3.0% |
|
A
Agilent Technologies, Inc.
|
$44.91B | +16.9% | +6.4% | 31.9 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on Sep 22, 2023; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PRPO | +29.6% | +28.6% | +23.4% | +40.7% | +32.5% |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | +30.9% | +25.0% | +11.8% | +38.2% | +20.2% |